<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39393058</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2291-5222</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>JMIR mHealth and uHealth</Title><ISOAbbreviation>JMIR Mhealth Uhealth</ISOAbbreviation></Journal><ArticleTitle>A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>e58991</StartPage><MedlinePgn>e58991</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e58991</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/58991</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SMS text messaging- and internet-based self-reporting systems can supplement existing vaccine safety surveillance systems, but real-world participation patterns have not been assessed at scale.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to describe the participation rates of a new SMS text messaging- and internet-based self-reporting system called the Kaiser Permanente Side Effect Monitor (KPSEM) within a large integrated health care system.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a prospective cohort study of Kaiser Permanente Southern California (KPSC) patients receiving a COVID-19 vaccination from April 23, 2021, to July 31, 2023. Patients received invitations through flyers, SMS text messages, emails, or patient health care portals. After consenting, patients received regular surveys to assess adverse events up to 5 weeks after each dose. Linkage with medical records provided demographic and clinical data. In this study, we describe KPSEM participation rates, defined as providing consent and completing at least 1 survey within 35 days of COVID-19 vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Approximately, 8% (164,636/2,091,975) of all vaccinated patients provided consent and completed at least 1 survey within 35 days. The lowest participation rates were observed for parents of children aged 12-17 years (1349/152,928, 0.9% participation rate), and the highest participation was observed among older adults aged 61-70 years (39,844/329,487, 12.1%). Persons of non-Hispanic White race were more likely to participate compared with other races and ethnicities (13.1% vs 3.9%-7.5%, respectively; P&lt;.001). In addition, patients residing in areas with a higher neighborhood deprivation index were less likely to participate (5.1%, 16,503/323,122 vs 10.8%, 38,084/352,939 in the highest vs lowest deprivation quintiles, respectively; P&lt;.001). Invitations through the individual's Kaiser Permanente health care portal account and by SMS text message were associated with the highest participation rate (19.2%, 70,248/366,377 and 10.5%, 96,169/914,793, respectively), followed by email (19,464/396,912, 4.9%) and then QR codes on flyers (25,882/2,091,975, 1.2%). SMS text messaging-based surveys demonstrated the highest sustained daily response rates compared with internet-based surveys.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This real-world prospective study demonstrated that a novel digital vaccine safety self-reporting system implemented through an integrated health care system can achieve high participation rates. Linkage with participants' electronic health records is another unique benefit of this surveillance system. We also identified lower participation among selected vulnerable populations, which may have implications when interpreting data collected from similar digital systems.</AbstractText><CopyrightInformation>©Debbie E Malden, Julianne Gee, Sungching Glenn, Zhuoxin Li, Denison S Ryan, Zheng Gu, Cassandra Bezi, Sunhea Kim, Amelia Jazwa, Michael M McNeil, Eric S Weintraub, Sara Y Tartof. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 11.10.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malden</LastName><ForeName>Debbie E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0003-0567-8294</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gee</LastName><ForeName>Julianne</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4244-8068</Identifier><AffiliationInfo><Affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glenn</LastName><ForeName>Sungching</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0041-0996</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuoxin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7593-4073</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Denison S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0001-8440-3859</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-5874-190X</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezi</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0000-1926-2201</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sunhea</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0228-9341</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazwa</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0097-2670</Identifier><AffiliationInfo><Affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeil</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0003-0713-8312</Identifier><AffiliationInfo><Affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weintraub</LastName><ForeName>Eric S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0003-0375-0504</Identifier><AffiliationInfo><Affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartof</LastName><ForeName>Sara Y</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0003-2336-8476</Identifier><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Mhealth Uhealth</MedlineTA><NlmUniqueID>101624439</NlmUniqueID><ISSNLinking>2291-5222</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060145" MajorTopicYN="Y">Text Messaging</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019033" MajorTopicYN="N">Delivery of Health Care, Integrated</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">US</Keyword><Keyword MajorTopicYN="N">USA</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">data collection</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">disparity</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">internet based</Keyword><Keyword MajorTopicYN="N">medical records</Keyword><Keyword MajorTopicYN="N">mobile phone</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">self-reporting</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword><Keyword MajorTopicYN="N">surveillance system</Keyword><Keyword MajorTopicYN="N">survey</Keyword><Keyword MajorTopicYN="N">survey participation</Keyword><Keyword MajorTopicYN="N">surveys</Keyword><Keyword MajorTopicYN="N">text</Keyword><Keyword MajorTopicYN="N">text message</Keyword><Keyword MajorTopicYN="N">text-based surveys</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">vaccine monitoring</Keyword><Keyword MajorTopicYN="N">vaccine safety</Keyword><Keyword MajorTopicYN="N">vaccine safety monitoring</Keyword><Keyword MajorTopicYN="N">vulnerable</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39393058</ArticleId><ArticleId IdType="pmc">PMC11512128</ArticleId><ArticleId IdType="doi">10.2196/58991</ArticleId><ArticleId IdType="pii">v12i1e58991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pew Research Center  Mobile fact sheet.  [2024-01-31].  
 https://www.pewresearch.org/internet/fact-sheet/mobile/
</Citation></Reference><Reference><Citation>Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)--United States, 1991-2001. MMWR Surveill Summ. 2003;52(1):1–24. 
 
</Citation><ArticleIdList><ArticleId IdType="pubmed">12825543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bota AB, Bettinger JA, Sarfo-Mensah S, Lopez J, Smith DP, Atkinson KM, Bell C, Marty K, Serhan M, Zhu DT, McCarthy AE, Wilson K. Comparing the use of a mobile app and a web-based notification platform for surveillance of adverse events following influenza immunization: randomized controlled trial. JMIR Public Health Surveill. 2023;9:e39700. doi: 10.2196/39700. 
 
v9i1e39700</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/39700</ArticleId><ArticleId IdType="pmc">PMC10203918</ArticleId><ArticleId IdType="pubmed">37155240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon WJ, Landman A, Zhang H, Bates DW. Beyond validation: getting health apps into clinical practice. NPJ Digit Med. 2020;3:14. doi: 10.1038/s41746-019-0212-z. doi: 10.1038/s41746-019-0212-z.212</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-019-0212-z</ArticleId><ArticleId IdType="doi">10.1038/s41746-019-0212-z</ArticleId><ArticleId IdType="pmc">PMC6997363</ArticleId><ArticleId IdType="pubmed">32047860</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh JW, Gerber BS, Gans CP, Kansal MM, Kitsiou S. Smartphone ownership and interest in mobile health technologies for self-care among patients with chronic heart failure: cross-sectional survey study. JMIR Cardio. 2022;6(1):e31982. doi: 10.2196/31982. 
 
v6i1e31982</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/31982</ArticleId><ArticleId IdType="pmc">PMC8800088</ArticleId><ArticleId IdType="pubmed">35029533</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudin A, Maatoug R, Bourla A, Ferreri F, Bonnot O, Millet B, Schoeller F, Mouchabac S, Adrien V. Digital phenotyping: data-driven psychiatry to redefine mental health. J Med Internet Res. 2023;25:e44502. doi: 10.2196/44502. 
 
v25i1e44502</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44502</ArticleId><ArticleId IdType="pmc">PMC10585447</ArticleId><ArticleId IdType="pubmed">37792430</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis VC, Thomas Craig KJ, Jabbarpour Y, Scheufele EL, Arriaga YE, Ajinkya M, Rhee KB, Bazemore A. Digital health interventions to enhance prevention in primary care: scoping review. JMIR Med Inform. 2022;10(1):e33518. doi: 10.2196/33518. 
 
v10i1e33518</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/33518</ArticleId><ArticleId IdType="pmc">PMC8817213</ArticleId><ArticleId IdType="pubmed">35060909</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Digital Health  Digital health equity for older populations. Lancet Digit Health. 2023;5(7):e395. doi: 10.1016/S2589-7500(23)00114-0. 
 
S2589-7500(23)00114-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00114-0</ArticleId><ArticleId IdType="pubmed">37391262</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao A, Xu Z, Skare M, Qin Y, Wang X. Bridging the digital divide: the impact of technological innovation on income inequality and human interactions. Humanit Soc Sci Commun. 2024;11:809. doi: 10.1057/s41599-024-03307-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-024-03307-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim H, Liu X, Zariffa N, Morris AD, Denniston AK. Health data poverty: an assailable barrier to equitable digital health care. Lancet Digit Health. 2021;3(4):e260–e265. doi: 10.1016/S2589-7500(20)30317-4. 
 
S2589-7500(20)30317-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30317-4</ArticleId><ArticleId IdType="pubmed">33678589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kc S, Tewolde S, Laverty AA, Costelloe C, Papoutsi C, Reidy C, Gudgin B, Shenton C, Majeed A, Powell J, Greaves F. Uptake and adoption of the NHS App in England: an observational study. Br J Gen Pract. 2023;73(737):e932–e940. doi: 10.3399/BJGP.2022.0150. 
 
BJGP.2022.0150</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2022.0150</ArticleId><ArticleId IdType="pmc">PMC10562999</ArticleId><ArticleId IdType="pubmed">37783512</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouwels K, Eyre DW, House T, Aspey B, Matthews PC, Stoesser N, Newton JN, Diamond I, Studley R, Taylor NGH, Bell JI, Farrar J, Kolenchery J, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Walker AS, COVID−19 Infection Survey Team Improving the representativeness of UK's national COVID-19 infection survey through spatio-temporal regression and post-stratification. Nat Commun. 2024;15(1):5340. doi: 10.1038/s41467-024-49201-4. doi: 10.1038/s41467-024-49201-4.10.1038/s41467-024-49201-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-49201-4</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-49201-4</ArticleId><ArticleId IdType="pmc">PMC11196632</ArticleId><ArticleId IdType="pubmed">38914564</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, Canas LS, Graham MS, Klaser K, Modat M, Murray B, Kerfoot E, Chen L, Deng J, Österdahl MF, Cheetham NJ, Drew DA, Nguyen LH, Pujol JC, Hu C, Selvachandran S, Polidori L, May A, Wolf J, Chan AT, Hammers A, Duncan EL, Spector TD, Ourselin S, Steves CJ. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55. doi: 10.1016/S1473-3099(21)00460-6. 
 
S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA. 2021;325(21):2201–2202. doi: 10.1001/jama.2021.5374.2778441</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5374</ArticleId><ArticleId IdType="pubmed">33818592</ArticleId></ArticleIdList></Reference><Reference><Citation>Drury RE, O'Connor D. Symptom study app provides real-world data on COVID-19 vaccines. Lancet Infect Dis. 2021;21(7):890–891. doi: 10.1016/S1473-3099(21)00264-4. 
 
S1473-3099(21)00264-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00264-4</ArticleId><ArticleId IdType="pmc">PMC8078875</ArticleId><ArticleId IdType="pubmed">33930321</ArticleId></ArticleIdList></Reference><Reference><Citation>Houhamdi L, Fournier PE. Smart apps for self-reporting clinical information. Lancet. 2022;399(10335):1575–1576. doi: 10.1016/S0140-6736(22)00453-6. 
 
S0140-6736(22)00453-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00453-6</ArticleId><ArticleId IdType="pmc">PMC8989392</ArticleId><ArticleId IdType="pubmed">35397852</ArticleId></ArticleIdList></Reference><Reference><Citation>Drury RE, O'Connor D. Symptom study app provides real-world data on COVID-19 vaccines. Lancet Infect Dis. 2021;21(7):890–891. doi: 10.1016/S1473-3099(21)00264-4. 
 
S1473-3099(21)00264-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00264-4</ArticleId><ArticleId IdType="pmc">PMC8078875</ArticleId><ArticleId IdType="pubmed">33930321</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, Hu C, Selvachandran S, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Modat M, Joshi AD, Mangino M, Hammers A, Goodman AL, Chan AT, Wolf J, Steves CJ, Valdes AM, Ourselin S, Spector TD. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi: 10.1016/S1473-3099(21)00224-3. 
 
S1473-3099(21)00224-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00224-3</ArticleId><ArticleId IdType="pmc">PMC8078878</ArticleId><ArticleId IdType="pubmed">33930320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MTH, Krause G, Keller-Stanislawski B, Glöckner S, Mentzer D, Ott JJ. Postmarketing safety monitoring after influenza vaccination using a mobile health app: prospective longitudinal feasibility study. JMIR Mhealth Uhealth. 2021;9(5):e26289. doi: 10.2196/26289. 
 
v9i5e26289</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26289</ArticleId><ArticleId IdType="pmc">PMC8140379</ArticleId><ArticleId IdType="pubmed">33960950</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MTH, Ott JJ, Caputo M, Keller-Stanislawski B, Klett-Tammen CJ, Linnig S, Mentzer D, Krause G. User preferences for a mobile application to report adverse events following vaccination. Pharmazie. 2020;75(1):27–31. doi: 10.1691/ph.2020.9734. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1691/ph.2020.9734</ArticleId><ArticleId IdType="pubmed">32033630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfes L, Härmark L, Kant A, van Balveren L, Hilgersom W, van Hunsel F. COVID-19 vaccine reactogenicity - a cohort event monitoring study in the Netherlands using patient reported outcomes. Vaccine. 2022;40(7):970–976. doi: 10.1016/j.vaccine.2022.01.013. 
 
S0264-410X(22)00028-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.01.013</ArticleId><ArticleId IdType="pmc">PMC8761555</ArticleId><ArticleId IdType="pubmed">35067381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K, Atkinson KM, Westeinde J, Bell C, Marty K, Fergusson D, Deeks SL, Crowcroft N, Bettinger JA. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination. Hum Vaccin Immunother. 2016;12(7):1738–1748. doi: 10.1080/21645515.2016.1152434. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2016.1152434</ArticleId><ArticleId IdType="pmc">PMC4964836</ArticleId><ArticleId IdType="pubmed">26905396</ArticleId></ArticleIdList></Reference><Reference><Citation>Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J, Elo I, Burke JG, O'Campo P. The development of a standardized neighborhood deprivation index. J Urban Health. 2006;83(6):1041–1062. doi: 10.1007/s11524-006-9094-x. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11524-006-9094-x</ArticleId><ArticleId IdType="pmc">PMC3261293</ArticleId><ArticleId IdType="pubmed">17031568</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G, CONSORT-EHEALTH Group  CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions. J Med Internet Res. 2011;13(4):e126. doi: 10.2196/jmir.1923. 
 
v13i4e126</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.1923</ArticleId><ArticleId IdType="pmc">PMC3278112</ArticleId><ArticleId IdType="pubmed">22209829</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-surveys (CHERRIES) J Med Internet Res. 2004;6(3):e34. doi: 10.2196/jmir.6.3.e34. 
 
v6e34</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.6.3.e34</ArticleId><ArticleId IdType="pmc">PMC1550605</ArticleId><ArticleId IdType="pubmed">15471760</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo EJ, Gee J, Marquez P, Baggs J, Abara WE, McNeil MM, Dimova RB, Su JR. Post-authorization safety surveillance of Ad.26.COV2.S vaccine: reports to the vaccine adverse event reporting system and v-safe, February 2021-February 2022. Vaccine. 2023;41(30):4422–4430. doi: 10.1016/j.vaccine.2023.06.023. 
 
S0264-410X(23)00687-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.06.023</ArticleId><ArticleId IdType="pmc">PMC10264169</ArticleId><ArticleId IdType="pubmed">37321898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard MS, Davis LM. Decline in trust in the centers for disease control and prevention during the COVID-19 pandemic. Rand Health Q. 2022;9(3):23. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242572</ArticleId><ArticleId IdType="pubmed">35837520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, Lawrence SJ, Thomas DR, Kellman S. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200–207. doi: 10.1097/QAI.0000000000002570. 
 
00126334-202102010-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002570</ArticleId><ArticleId IdType="pmc">PMC7808278</ArticleId><ArticleId IdType="pubmed">33196555</ArticleId></ArticleIdList></Reference><Reference><Citation>Panickar R, Aziz Z, Mohd Sani N, Kamarulzaman A. The use of technology in vaccine safety communication: a systematic review of randomised controlled trials. Patient Educ Couns. 2023;112:107707. doi: 10.1016/j.pec.2023.107707.S0738-3991(23)00087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2023.107707</ArticleId><ArticleId IdType="pubmed">36989861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, Wellington E, Stowe J, Gillson N, Atti A, Islam J, Karagiannis I, Munro K, Khawam J, Chand MA, Brown CS, Ramsay M, Lopez-Bernal J, Hopkins S, SIREN Study Group  COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725–1735. doi: 10.1016/S0140-6736(21)00790-X. 
 
S0140-6736(21)00790-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00790-X</ArticleId><ArticleId IdType="pmc">PMC8064668</ArticleId><ArticleId IdType="pubmed">33901423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson C, Watson E, Certa JM, Gordon KS, Park LS, D'Souza G, Benning L, Abraham AG, Agil D, Napravnik S, Silverberg MJ, Leyden WA, Skarbinski J, Williams C, Althoff KN, Horberg MA, NA-ACCORD Corona-Infectious-Virus Epidemiology Team (CIVET)  Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLoS One. 2022;17(11):e0276742. doi: 10.1371/journal.pone.0276742. 
 
PONE-D-22-12703</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276742</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0276742</ArticleId><ArticleId IdType="pmc">PMC9683575</ArticleId><ArticleId IdType="pubmed">36417366</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian L, Sy LS, Hong V, Glenn SC, Ryan DS, Morrissette K, Jacobsen SJ, Xu S. Disparities in outpatient and telehealth visits during the COVID-19 pandemic in a large integrated health care organization: retrospective cohort study. J Med Internet Res. 2021;23(9):e29959. doi: 10.2196/29959. 
 
v23i9e29959</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29959</ArticleId><ArticleId IdType="pmc">PMC8412134</ArticleId><ArticleId IdType="pubmed">34351865</ArticleId></ArticleIdList></Reference><Reference><Citation>Palzes VA, Chi FW, Metz VE, Sterling S, Asyyed A, Ridout KK, Campbell CI. Overall and telehealth addiction treatment utilization by age, race, ethnicity, and socioeconomic status in California after COVID-19 policy changes. JAMA Health Forum. 2023;4(5):e231018. doi: 10.1001/jamahealthforum.2023.1018. 
 
2804987</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.1018</ArticleId><ArticleId IdType="pmc">PMC10199344</ArticleId><ArticleId IdType="pubmed">37204804</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Digital Health Power to the people. Lancet Digital Health. 2021;3(8):e462. doi: 10.1016/s2589-7500(21)00147-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(21)00147-3</ArticleId><ArticleId IdType="pubmed">34325849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chantasrisawad N, Puthanakit T, Tangsathapornpong A, Techasaensiri C, Phongsamart W, Suwanpakdee D, Jaruampornpan P, Sophonphan J, Suntarattiwong P, Chotpitayasunondh T, Study Team  Immunogenicity and reactogenicity of mRNA BNT162b2 COVID-19 vaccine among thai adolescents with chronic diseases. Vaccines (Basel) 2022;10(6):871. doi: 10.3390/vaccines10060871. 
 
vaccines10060871</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060871</ArticleId><ArticleId IdType="pmc">PMC9229070</ArticleId><ArticleId IdType="pubmed">35746478</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos G, Eckermann T, Martínez-Gómez X, Parra J, Nwoji U, Salamanca de la Cueva I. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring. Influenza Other Respir Viruses. 2023;17(3):e13098. doi: 10.1111/irv.13098. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13098</ArticleId><ArticleId IdType="pmc">PMC10040952</ArticleId><ArticleId IdType="pubmed">36991538</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AB, Mathews SC, Dorsey ER, Bates DW, Safavi K. Direct-to-consumer digital health. Lancet Digit Health. 2020;2(4):e163–e165. doi: 10.1016/S2589-7500(20)30057-1. 
 
S2589-7500(20)30057-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30057-1</ArticleId><ArticleId IdType="pubmed">33328077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>